| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Executive VP, Head Of R&D | See Remarks
1 company
Ho Tony W is an Executive VP, Head Of R&D at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $2.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2020 | CRSP Crispr Therapeutics AG | Executive VP, Head Of R&D | Sale+OE | 23,551 | $149.23 | $3,514,610.11 | -5.2% | |
| Jun 23, 2020 | CRSP Crispr Therapeutics AG | Executive VP, Head Of R&D | Sell | 7,158 | $75.04 | $537,122.86 | -8.8% | |
| May 26, 2020 | CRSP Crispr Therapeutics AG | Executive VP, Head Of R&D | Sell | 6,700 | $70.13 | $469,884.00 | -7.1% |